Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor.

MLA

Helmstädter, Johanna, et al. “Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Their Cardiovascular Benefits-The Role of the GLP-1 Receptor.” British Journal of Pharmacology, vol. 179, no. 4, Feb. 2022, pp. 659–76. EBSCOhost, https://doi.org/10.1111/bph.15462.

APA

Helmstädter, J., Keppeler, K., Küster, L., Münzel, T., Daiber, A., & Steven, S. (2022). Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor. British Journal of Pharmacology, 179(4), 659–676. https://doi.org/10.1111/bph.15462

Chicago

Helmstädter, Johanna, Karin Keppeler, Leonie Küster, Thomas Münzel, Andreas Daiber, and Sebastian Steven. 2022. “Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Their Cardiovascular Benefits-The Role of the GLP-1 Receptor.” British Journal of Pharmacology 179 (4): 659–76. doi:10.1111/bph.15462.